Università La Sapienza - Centro Ambulatorio Cefalee, I.C.O.T.
- Address
- Via Franco Faggiana 1668, 04100 Latina, Italy
Università La Sapienza - Centro Ambulatorio Cefalee, I.C.O.T.
The Centro Ambulatorio Cefalee at Università La Sapienza's I.C.O.T. facility is a specialized headache center dedicated to advancing the understanding and treatment of migraine disorders. The center focuses on innovative therapeutic approaches for migraine prevention, with particular expertise in pediatric and adolescent headache management.
- Migraine prevention strategies in children and adolescents aged 6 to 18 years
- Novel pharmacological interventions including CGRP receptor antagonists
- Clinical evaluation of episodic migraine with and without aura
The center actively participates in Phase 3 clinical trials evaluating cutting-edge preventive therapies for episodic migraine in younger populations. Through rigorous double-blind, placebo-controlled studies, the research team contributes to establishing evidence-based treatment protocols that measure efficacy in reducing monthly migraine days, ultimately improving quality of life for pediatric and adolescent patients suffering from this debilitating neurological condition.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pfizer Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Università La Sapienza - Centro Ambulatorio Cefalee, I.C.O.T.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Rimegepant for Migraine Prophylaxis in Pediatric Patients Aged 6 to <18 Years: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial | Pfizer Inc. | Phase III | Recruiting | Oct 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rimegepant | 1 | Unknown | 2022-10-04 | 2022-10-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.